blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3488857

EP3488857 - COMPOSITIONS OF GLP-1 PEPTIDES AND PREPARATION THEREOF [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  05.05.2023
Database last updated on 11.09.2024
FormerGrant of patent is intended
Status updated on  28.09.2022
FormerExamination is in progress
Status updated on  17.07.2020
FormerRequest for examination was made
Status updated on  06.12.2019
FormerThe application has been published
Status updated on  26.04.2019
Most recent event   Tooltip22.07.2024New entry: Reply of patent proprietor to notice(s) of opposition 
Applicant(s)For all designated states
Novo Nordisk A/S
Novo Allé
2880 Bagsværd / DK
[2019/22]
Inventor(s)01 / HANSEN, Tue
Novo Nordisk A/S
Novo Allé
2880 Bagsværd / DK
02 / VILHELMSEN, Thomas
Novo Nordisk A/S
Novo Allé
2880 Bagsværd / DK
03 / ELIASEN, Helle
Novo Nordisk A/S
Novo Allé
2880 Bagsværd / DK
 [2019/22]
Representative(s)D Young & Co LLP
3 Noble Street
London EC2V 7BQ / GB
[N/P]
Application number, filing date18188815.715.03.2013
[2019/22]
Priority number, dateEP2012016074322.03.2012         Original published format: EP 12160743
US201361748840P04.01.2013         Original published format: US 201361748840 P
EP2013015345931.01.2013         Original published format: EP 13153459
[2019/22]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3488857
Date:29.05.2019
Language:EN
[2019/22]
Type: B1 Patent specification 
No.:EP3488857
Date:07.06.2023
Language:EN
[2023/23]
Type: B9 Corrected patent specification 
No.:EP3488857
Date:04.10.2023
[2023/40]
Search report(s)(Supplementary) European search report - dispatched on:EP01.04.2019
ClassificationIPC:A61K38/26, A61P3/10, A61K47/00
[2019/22]
CPC:
A61K38/26 (EP,CN,KR,US); A61K31/20 (EP,US); A61K47/06 (KR);
A61K47/50 (KR); A61K9/16 (KR); A61K9/2013 (EP,CN,KR,US);
A61K9/2077 (EP,CN,KR,US); A61P3/00 (EP); A61P3/04 (EP,KR);
A61P3/10 (EP,KR) (-)
C-Set:
A61K31/20, A61K2300/00 (US,EP);
A61K38/26, A61K2300/00 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/02]  
Former [2019/22]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:ZUSAMMENSETZUNGEN VON GLP-1-PEPTIDEN UND HERSTELLUNG DAVON[2019/22]
English:COMPOSITIONS OF GLP-1 PEPTIDES AND PREPARATION THEREOF[2019/22]
French:COMPOSITIONS DE PEPTIDES GLP-1 ET LEUR PRÉPARATION[2019/22]
Examination procedure27.11.2019Amendment by applicant (claims and/or description)
29.11.2019Examination requested  [2020/02]
29.11.2019Date on which the examining division has become responsible
20.07.2020Despatch of a communication from the examining division (Time limit: M06)
27.01.2021Reply to a communication from the examining division
06.07.2021Despatch of a communication from the examining division (Time limit: M04)
15.11.2021Reply to a communication from the examining division
29.09.2022Communication of intention to grant the patent
31.01.2023Fee for grant paid
31.01.2023Fee for publishing/printing paid
31.01.2023Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP13709231.8  / EP2827885
Divisional application(s)EP23177173.4  / EP4324475
Opposition(s)Opponent(s)01  05.03.2024  07.03.2024  ADMISSIBLE
Strawman Limited
Orchard Lea
Horns Lane
Combe, Witney
Oxfordshire OX29 8NH / GB
Opponent's representative
Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
 02  07.03.2024  08.03.2024  ADMISSIBLE
Generics (U.K.) Limited
Building 4, Trident Place
Mosquito Way
Hatfield
Hertfordshire AL10 9UL / GB
Opponent's representative
Ter Meer Steinmeister & Partner
Patentanwälte mbB
Nymphenburger Straße 4
80335 München / DE
 03  07.03.2024  08.03.2024  ADMISSIBLE
Hamm&Wittkopp Patentanwälte PartmbB
Jungfernstieg 38
20354 Hamburg / DE
Opponent's representative
Hamm&Wittkopp Patentanwälte PartmbB
Jungfernstieg 38
20354 Hamburg / DE
 04  07.03.2024  08.03.2024  ADMISSIBLE
ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
ul. Pelplinska 19
83-200 Starogard Gdanski / PL
Opponent's representative
Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
 05  07.03.2024  08.03.2024  ADMISSIBLE
Hexal AG
Industriestrasse 25
83607 Holzkirchen / DE
Opponent's representative
Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
 [2024/16]
Former [2024/15]
Opponent(s)01  05.03.2024  07.03.2024  ADMISSIBLE
Strawman Limited
Orchard Lea
Horns Lane
Combe, Witney
Oxfordshire OX29 8NH / GB
Opponent's representative
Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
22.03.2024Invitation to proprietor to file observations on the notice of opposition
22.07.2024Reply of patent proprietor to notice(s) of opposition
Fees paidRenewal fee
14.12.2018Renewal fee patent year 03
14.12.2018Renewal fee patent year 04
14.12.2018Renewal fee patent year 05
14.12.2018Renewal fee patent year 06
01.04.2019Renewal fee patent year 07
31.03.2020Renewal fee patent year 08
31.03.2021Renewal fee patent year 09
31.03.2022Renewal fee patent year 10
31.03.2023Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipSM07.06.2023
IS07.10.2023
[2024/09]
Former [2024/08]SM07.06.2023
Documents cited:Search[AD]WO2006097537  (NOVO NORDISK AS [DK], et al);
 [X]US2009124639  (OYEWUMI MOSES [US], et al);
 [XP]WO2012080471  (NOVO NORDISK AS [DK], et al);
by applicantWO9319175
 WO9629342
 WO9630036
 WO9808871
 WO9943707
 WO9943706
 WO9943341
 WO9943708
 WO0046182
 WO0192206
 WO2005027978
 WO2005058954
 WO2005058958
 WO2006005667
 WO2006037810
 WO2006037811
 WO2006097537
 WO2006097538
 WO2007121318
 WO2008023050
 WO2008028859
 WO2009030738
 WO2009030771
 WO2009030774
 WO2009083549
OppositionWO2005107462
 WO2006084164
 WO2006124047
 WO2008003050
 WO2012080471
 WO2013189988
 WO2007146234
 WO2013139694
 EP3488857
 WO2006097537
 JP4585037B
 WO2011094531
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.